Invention Grant
- Patent Title: Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer
-
Application No.: US16475223Application Date: 2018-01-02
-
Publication No.: US11377491B2Publication Date: 2022-07-05
- Inventor: X. Charlene Liao , Qiang Liu , Zhiqiang An , Ningyan Zhang , Xun Gui , Chengcheng Zhang , Mi Deng , Jingjing Xie
- Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander, PLLC
- International Application: PCT/US2018/012040 WO 20180102
- International Announcement: WO2018/126259 WO 20180705
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C12N5/12 ; C12N15/85
Abstract:
The present disclosure is directed to antibodies binding to LAIR 1 and their treating cancer, inflammation, immune-related diseases or transplantation.
Public/Granted literature
- US20190338026A1 ANTI-LAIR1 ANTIBODIES AND THEIR USES Public/Granted day:2019-11-07
Information query
